Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prostate cancer treatment and diagnosis ...
Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the ...
Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...
Governor Ivey has signed a new law that will make prostate cancer screenings more affordable. It will require insurance companies to fully cover prostate cancer screenings for certain individuals.
Morning Overview on MSN
Study finds microplastics in 90% of prostate cancer tumors
Researchers at NYU Langone Health have detected tiny plastic fragments in nine out of 10 prostate cancer tumors examined, a ...
Like most diseases, prostate cancer is most treatable and curable when caught early. Now, there's new hope for men diagnosed ...
For men, prostate cancer is one of the greatest health risks. While there are various factors at play, your diet is one you can control. Unfortunately, these otherwise health foods may increase your ...
Former first lady Jill Biden has issued a rare health update on Joe Biden's battle with prostate cancer, saying that the former president is "doing well." ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...
Data from Vista Health, a leading UK provider of private diagnostic services, has revealed the worrying knowledge gap when it comes to the prostate, as 26 percent of men do not know what their ...
Stockhead on MSN
Health Check: Telix jumps first hurdle with its advanced prostate cancer therapy trial
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果